Literature DB >> 26279905

Crystal structure of 2-cyano-N-(furan-2-ylmeth-yl)acetamide.

Shivanna Subhadramma1, Budanur Papaiah Siddaraju2, Chandra Naveen3, Janardhanan Saravanan4, Dasararaju Gayathri5.   

Abstract

In the title compound, C8H8N2O2, the acetamide unit is inclined to the furan ring by 76.7 (1)°. In the crystal, mol-ecules are linked by N-H⋯O and C-H⋯O hydrogen bonds, generating C(4) chains along [100]. The carbonyl O atom is a bifurcated acceptor and an R (1) 2(6) ring is formed.

Entities:  

Keywords:  acetamide; bifurcated hydrogen bonding.; crystal structure; cyano; furan

Year:  2015        PMID: 26279905      PMCID: PMC4518919          DOI: 10.1107/S2056989015010488

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

For examples of biological properties of furan derivatives, see: Anupam et al. (2011 ▸). For the biological activities of some heterocyclic derivatives containing the acetamide moiety, see: Fallah-Tafti et al. (2011 ▸); Shams et al. (2011 ▸). For a related acetamide structure, see: Jasinski et al. (2013 ▸). For the crystal structure of similar compound, 2-cyano-N-furfuryl-3-(2-fur­yl)acryl­amide, see: Pomés Hernández et al. (1996 ▸).

Experimental

Crystal data

C8H8N2O2 M = 164.16 Monoclinic, a = 4.8093 (4) Å b = 14.9495 (16) Å c = 11.4969 (11) Å β = 93.482 (3)° V = 825.06 (14) Å3 Z = 4 Mo Kα radiation μ = 0.10 mm−1 T = 293 K 0.3 × 0.2 × 0.2 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2004 ▸) T min = 0.946, T max = 0.986 7302 measured reflections 1455 independent reflections 1175 reflections with I > 2σ(I) R int = 0.027

Refinement

R[F 2 > 2σ(F 2)] = 0.037 wR(F 2) = 0.111 S = 1.09 1455 reflections 109 parameters H-atom parameters constrained Δρmax = 0.14 e Å−3 Δρmin = −0.13 e Å−3

Data collection: APEX2 (Bruker, 2004 ▸); cell refinement: APEX2 and SAINT (Bruker, 2004 ▸); data reduction: SAINT and XPREP (Bruker, 2004 ▸); program(s) used to solve structure: SHELXS2014/7 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL2014/7 (Sheldrick, 2015 ▸); molecular graphics: PLATON (Spek, 2009 ▸); software used to prepare material for publication: SHELXL2014/7 and PLATON. Crystal structure: contains datablock(s) I, globa. DOI: 10.1107/S2056989015010488/su5145sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015010488/su5145Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015010488/su5145Isup3.cml Click here for additional data file. . DOI: 10.1107/S2056989015010488/su5145fig1.tif The mol­ecular structure of the title compound, with atom labelling. The displacement ellipsoids are drawn at the 30% probability level. Click here for additional data file. b . DOI: 10.1107/S2056989015010488/su5145fig2.tif A view along the b axis of the crystal packing of the title compound. The hydrogen bonds are shown as dashed lines (see Table 1 for details). CCDC reference: 1404031 Additional supporting information: crystallographic information; 3D view; checkCIF report
C8H8N2O2F(000) = 344
Mr = 164.16Dx = 1.322 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 4.8093 (4) ÅCell parameters from 1455 reflections
b = 14.9495 (16) Åθ = 2.2–25.0°
c = 11.4969 (11) ŵ = 0.10 mm1
β = 93.482 (3)°T = 293 K
V = 825.06 (14) Å3Block, colourless
Z = 40.3 × 0.2 × 0.2 mm
Bruker APEXII CCD diffractometer1455 independent reflections
Radiation source: fine-focus sealed tube1175 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.027
Detector resolution: 8.0216 pixels mm-1θmax = 25.0°, θmin = 2.2°
ω and φ scanh = −5→5
Absorption correction: multi-scan (SADABS; Bruker, 2004)k = −17→17
Tmin = 0.946, Tmax = 0.986l = −12→13
7302 measured reflections
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.037H-atom parameters constrained
wR(F2) = 0.111w = 1/[σ2(Fo2) + (0.0542P)2 + 0.1342P] where P = (Fo2 + 2Fc2)/3
S = 1.09(Δ/σ)max < 0.001
1455 reflectionsΔρmax = 0.14 e Å3
109 parametersΔρmin = −0.13 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
C10.6009 (4)0.71318 (14)0.26789 (17)0.0705 (5)
H1A0.71230.76160.25020.085*
C20.6246 (4)0.65991 (17)0.37051 (16)0.0816 (6)
H20.75490.66670.43300.098*
C30.4271 (5)0.59926 (15)0.36003 (17)0.0777 (6)
H30.39420.55580.41540.093*
C40.3883 (3)0.68024 (10)0.20223 (13)0.0483 (4)
C50.2563 (3)0.70388 (11)0.08709 (13)0.0575 (4)
H5A0.05590.70570.09250.069*
H5B0.31700.76330.06600.069*
C60.1307 (3)0.59915 (10)−0.07049 (12)0.0443 (4)
C70.2372 (3)0.54182 (11)−0.16707 (12)0.0506 (4)
H7A0.43730.5489−0.16940.061*
H7B0.19830.4793−0.15220.061*
C80.1019 (4)0.56845 (11)−0.27806 (15)0.0590 (4)
N10.3219 (2)0.64139 (9)−0.00467 (10)0.0467 (3)
H10.49420.6316−0.01640.056*
N2−0.0079 (5)0.59089 (12)−0.36283 (16)0.0947 (6)
O10.2779 (2)0.60909 (8)0.25698 (10)0.0649 (4)
O2−0.1197 (2)0.60352 (9)−0.05760 (11)0.0713 (4)
U11U22U33U12U13U23
C10.0617 (10)0.0790 (13)0.0714 (12)−0.0144 (9)0.0087 (9)−0.0277 (10)
C20.0772 (13)0.1118 (17)0.0535 (11)0.0191 (13)−0.0147 (9)−0.0260 (11)
C30.1019 (15)0.0806 (14)0.0500 (10)0.0116 (12)−0.0012 (10)−0.0002 (9)
C40.0465 (8)0.0503 (9)0.0491 (8)0.0010 (7)0.0112 (6)−0.0087 (7)
C50.0624 (10)0.0576 (10)0.0535 (9)0.0132 (8)0.0110 (7)−0.0042 (7)
C60.0312 (7)0.0565 (9)0.0455 (8)0.0070 (6)0.0038 (6)0.0080 (7)
C70.0404 (7)0.0614 (10)0.0497 (9)0.0038 (7)0.0004 (6)−0.0016 (7)
C80.0713 (11)0.0528 (10)0.0526 (10)−0.0083 (8)0.0015 (8)0.0013 (8)
N10.0339 (6)0.0611 (8)0.0458 (7)0.0072 (5)0.0079 (5)−0.0030 (6)
N20.1407 (18)0.0789 (12)0.0611 (10)−0.0056 (11)−0.0226 (11)0.0125 (9)
O10.0713 (8)0.0667 (8)0.0568 (7)−0.0098 (6)0.0037 (6)0.0023 (6)
O20.0304 (6)0.1024 (10)0.0816 (9)0.0076 (6)0.0088 (5)−0.0081 (7)
C1—C41.328 (2)C5—H5A0.9700
C1—C21.422 (3)C5—H5B0.9700
C1—H1A0.9300C6—O21.2238 (16)
C2—C31.314 (3)C6—N11.3162 (18)
C2—H20.9300C6—C71.516 (2)
C3—O11.355 (2)C7—C81.452 (2)
C3—H30.9300C7—H7A0.9700
C4—O11.3602 (19)C7—H7B0.9700
C4—C51.476 (2)C8—N21.131 (2)
C5—N11.4579 (19)N1—H10.8600
C4—C1—C2106.51 (18)C4—C5—H5B108.9
C4—C1—H1A126.7H5A—C5—H5B107.7
C2—C1—H1A126.7O2—C6—N1124.26 (14)
C3—C2—C1106.82 (17)O2—C6—C7119.83 (13)
C3—C2—H2126.6N1—C6—C7115.90 (12)
C1—C2—H2126.6C8—C7—C6109.59 (13)
C2—C3—O1110.29 (18)C8—C7—H7A109.8
C2—C3—H3124.9C6—C7—H7A109.8
O1—C3—H3124.9C8—C7—H7B109.8
C1—C4—O1109.60 (15)C6—C7—H7B109.8
C1—C4—C5134.05 (17)H7A—C7—H7B108.2
O1—C4—C5116.34 (13)N2—C8—C7178.0 (2)
N1—C5—C4113.30 (13)C6—N1—C5123.31 (12)
N1—C5—H5A108.9C6—N1—H1118.3
C4—C5—H5A108.9C5—N1—H1118.3
N1—C5—H5B108.9C3—O1—C4106.78 (14)
C4—C1—C2—C3−0.1 (2)N1—C6—C7—C8−125.10 (14)
C1—C2—C3—O10.5 (2)O2—C6—N1—C5−4.5 (2)
C2—C1—C4—O1−0.39 (19)C7—C6—N1—C5175.82 (13)
C2—C1—C4—C5−179.82 (17)C4—C5—N1—C6124.16 (16)
C1—C4—C5—N1105.9 (2)C2—C3—O1—C4−0.7 (2)
O1—C4—C5—N1−73.48 (17)C1—C4—O1—C30.70 (18)
O2—C6—C7—C855.19 (19)C5—C4—O1—C3−179.76 (14)
D—H···AD—HH···AD···AD—H···A
N1—H1···O2i0.861.992.846 (1)175
C7—H7A···O2i0.972.553.395 (2)145
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N1H1O2i 0.861.992.846(1)175
C7H7AO2i 0.972.553.395(2)145

Symmetry code: (i) .

  6 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities.

Authors:  Asal Fallah-Tafti; Alireza Foroumadi; Rakesh Tiwari; Amir Nasrolahi Shirazi; David G Hangauer; Yahao Bu; Tahmineh Akbarzadeh; Keykavous Parang; Abbas Shafiee
Journal:  Eur J Med Chem       Date:  2011-08-04       Impact factor: 6.514

3.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

4.  Novel synthesis and antitumor evaluation of polyfunctionally substituted heterocyclic compounds derived from 2-cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-acetamide.

Authors:  Hoda Z Shams; Rafat M Mohareb; Maher H Helal; Amira E Mahmoud
Journal:  Molecules       Date:  2010-12-27       Impact factor: 4.411

5.  N-(4-Bromo-phen-yl)acetamide: a new polymorph.

Authors:  Jerry P Jasinski; Curtis J Guild; H S Yathirajan; B Narayana; S Samshuddin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-02-28

6.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.